A partnership has been reached by Senseonics, Roche Diabetes Care and TypeZero Technologies to create an automated insulin delivery system through the integration of Senseonic's Eversense glucose monitor, TypeZero's inControl AP algorithms and Roche's Accu-Chek Insight insulin pump. The collaboration comes as part of an NIH-funded trial of artificial pancreas systems.
Senseonics partners with Roche, TypeZero on automated insulin delivery system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.